Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)
Clinical trial NCT02728778 · COMPLETED
Trial details
- NCT number
- NCT02728778
- Sponsor
- Hannover Medical School
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-04-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.